Chugai Pharmaceutical Co (CUP) Income Statement
Chugai Pharmaceutical Co Income Statement
Last quarter (Q3 2026), Chugai Pharmaceutical Co's total revenue was $404.74B, an increase of 21.48% from the same quarter last year. In Q3, Chugai Pharmaceutical Co's net income was $143.55B. See Chugai Pharmaceutical Co’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 1.26T | $ 1.17T | $ 1.11T | $ 1.26T | $ 999.76B | |
| $ 894.25B | $ 830.75B | $ 693.01B | $ 783.06B | $ 660.27B | |
| $ 304.06B | $ 286.84B | $ 277.34B | $ 249.12B | $ 226.53B | |
| Depreciation and Amortization | $ 32.53B | $ 31.66B | $ 31.74B | $ 31.43B | $ 30.87B |
| $ 631.37B | $ 574.80B | $ 475.64B | $ 562.66B | $ 450.30B | |
| $ 590.19B | $ 543.91B | $ 415.67B | $ 533.94B | $ 433.74B | |
| $ 7.62B | $ -873.00M | $ 28.16B | $ -2.78B | $ -14.35B | |
| $ 597.81B | $ 543.03B | $ 443.82B | $ 531.17B | $ 419.38B | |
| $ 434.01B | $ 387.32B | $ 325.47B | $ 374.43B | $ 303.00B | |
| Per Share Metrics | |||||
| Basic EPS | $ 263.73 | $ 235.39 | $ 197.83 | $ 227.64 | $ 184.29 |
| Diluted EPS | $ 263.72 | $ 235.36 | $ 197.80 | $ 227.57 | $ 184.17 |
| Weighted Average Shares Outstanding | 1.65B | 1.65B | 1.65B | 1.64B | 1.64B |
| Weighted Average Shares Outstanding (Diluted) | 1.65B | 1.65B | 1.65B | 1.65B | 1.65B |
Currency in JPY